Used in pharmaceutical synthesis as an intermediate for developing potent anticoagulant agents. Shows high affinity in inhibiting specific serine proteases involved in blood coagulation pathways. Its structure enables selective binding, making it valuable in creating novel oral anticoagulants with improved safety profiles. Also investigated for use in treatments requiring controlled thrombin inhibition, such as in prevention of deep vein thrombosis and stroke in atrial fibrillation patients.